Related Experiment Video
Updated: Aug 4, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Feasibility and prospects for a vaccine to prevent cryptococcosis
Arturo Casadevall1, Liise-Anne Pirofski
1Division of Infectious Diseases of the Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA. casadeva@aecom.yu.edu
Abstract:
Cryptococcosis is a relatively common fungal disease caused by Cryptococcus neoformans that has high morbidity and mortality. Numerous studies have established the feasibility of enhancing host immunity to C neoformans in naive immunocompetent animal models by vaccination. Several antigens have been identified that appear to be suitable vaccine candidates. Induced immune responses can mediate protection through both humoral and cellular immunity. Hence, a vaccine against cryptococcosis in humans is probably feasible but there are significant obstacles to vaccine development that range from uncertainties about the pathogenesis of infection to economic considerations.
Related Concept Videos
Rocky Mountain Spotted Fever
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis

